3.1. Patient Demographics and Clinical Characteristics
The study included a total of 33 patients enrolled between December 2023 and December 2024, who underwent ureteral stent placement either as an emergency procedure for obstructive urolithiasis or electively for chronic conditions such as oncological diseases and retroperitoneal fibrosis. The study was conducted with a small sample size, which limits its statistical power and increases the likelihood that its findings are due to chance rather than true effects (
Table 1).
The mean age of the patients was 49.24 years. Regarding sex distribution, there was a predominance of male patients, with 19 men and 14 women included in the study.
The most frequently encountered comorbidities were arterial hypertension (33.3%) and diabetes mellitus (18.2%). Other comorbidities included obesity (12.1%), oncological conditions (6.1%), and retroperitoneal fibrosis (3%). Additionally, four patients were receiving anticoagulant therapy. Only five patients had no associated comorbidities.
Patients were categorized into four groups according to the stent’s intended duration and the actual indwelling period. Among those with stents designed for a 3-month duration, six patients had stents in place for less than 45 days, fourteen patients had stents for a period between 45 and 90 days, and nine patients had stents retained for more than 90 days. The latter were classified as having neglected ureteral stents. The fourth group included four patients who received 12-month stents due to chronic conditions that required urinary tract decompression, such as ureteral strictures or retroperitoneal fibrosis.
Although two patients had bilateral ureteral stents, only one procedure per patient was considered in the analysis for consistency.
3.2. Characteristics of Ureteral Stents
The material used to produce the ureteral stents was polyurethane. A total of 33 stents were used, each measuring 26 cm in length, with diameters ranging from 4.7 Fr to 7 Fr. Ureteral stents with calibers of 5 Fr, 8 Fr, or 10 Fr were not employed in this study (
Table 2).
The incidence of stent placement was higher on the left side compared to the right (21 versus 12 cases, respectively). The indication for ureteral stent insertion was either emergency intervention in cases of obstructive lithiasis or elective placement in patients with retroperitoneal fibrosis or oncological conditions causing ureteral stenosis.
The correlation between the degree of encrustation and the associated pathologies reported and recorded in this study (obesity, retroperitoneal fibrosis, and under antiplatelet treatment) showed statistically significant results in cases of low encrustation (
p < 0.001). However, no statistically significant correlation was observed in cases of moderate or severe encrustation (
Table 3).
Moreover, the presence of associated pathologies was found to promote the occurrence of urinary tract infections, particularly in cases involving
E. coli (
p < 0.05),
Klebsiella, and
Enterococcus species (
p < 0.001). Additionally, stent discoloration, specifically black pigmentation, was significantly associated with the presence of these pathogens, with statistically significant results (
p < 0.001) (
Table 4 and
Table 5).
Regarding the caliber of the ureteral stents, statistically significant results were observed in association with black discoloration across all sizes used (4.7 Fr, 6 Fr, and 7 Fr) (
p < 0.001). Low encrustations were recorded for all calibers as well, with statistically significant findings (
p < 0.001) (
Table 6).
The indwelling duration of ureteral stents influences the occurrence of low encrustations. Among patients who received stents with a 3-month intended duration, a significant positive association was observed between low encrustation and stent retention for 45–90 days (
p = 0.008) as well as for more than 90 days (
p = 0.01) (
Table 7).
No statistically significant correlations were identified between the presence of urinary tract infections and the degree of ureteral stent encrustation.
There were no statistically significant differences regarding brown stent discoloration among patients with stents retained for less than 45 days, stents retained for 45–90 days, 1-year indwelling stents, or neglected stents.
However, statistically significant differences were found between the three stent indwelling duration groups (<45 days, 45–90 days, >90 days) and the presence of black discoloration. As the duration of stent retention increased, black discoloration became more frequent.
A statistically significant difference was observed between patients with stents retained for less than 45 days and those with stents retained for 350–366 days, with black discoloration being more frequently found in the latter group (p = 0.005 *).
Additionally, statistically significant differences were recorded between patients with stents retained for 45–90 days and those with 350–366-day stents in terms of black discoloration (p < 0.001 **).
Furthermore, a significant difference was observed between patients with stents retained for 350–366 days and those with stents retained for more than 90 days, with black discoloration being less frequently observed in the latter group compared to the former (
p = 0.01 *) (
Table 8).
The type of surgical intervention required was closely associated with the duration of ureteral stent indwelling. Patients with stents maintained for longer periods, particularly those exceeding 90 days or those classified as neglected, more frequently required complex surgical procedures such as flexible ureteroscopy with laser lithotripsy or combined endourological approaches. In contrast, patients with stents retained for less than 45 days most commonly underwent standard cystoscopic removal, with minimal need for adjunctive surgical maneuvers. These findings suggest that prolonged stent retention increases the likelihood of requiring more invasive or technically demanding surgical interventions.
In the patient group with ureteral stents retained for less than 45 days, the most frequently associated interventions during stent removal were distal loop fragmentation and rigid or flexible ureteroscopy. Among patients with stents retained for 45–90 days, ureteroscopy (URS/FURS) was performed in 71.4% of cases, while in the neglected stent group (>90 days), it was required in 80% of cases. In contrast, for patients with long-term indwelling stents (validity of 1 year), this intervention was necessary in only 33.3% of cases.
Distal loop fragmentation was performed in 50% of patients in the <45-day group, in 42.9% of those in the 45–90-day group, and in 40% of patients with neglected stents (>90 days).
Ureteral stents were subsequently removed either by cystoscopy or ureteroscopy, depending on the complexity of encrustation and the surgical approach required (
Table 9).
The localization of encrustations was found to vary significantly depending on the duration of stent indwelling. Encrustations at the distal loop of the stent were identified in 83% of patients with stents retained for less than 45 days, in 92% of those with stents maintained for 45–90 days, and in 80% of patients with neglected stents (>90 days). In contrast, only 33% of patients with long-term stents (valid for up to one year) presented with encrustations at the distal loop.
Encrustations located along the body of the stent were observed in 50% of cases with neglected stents. Proximal loop encrustation was recorded in 70% of these patients, indicating a higher degree of overall stent colonization in prolonged indwelling scenarios.
These findings suggest that shorter indwelling times tend to result in encrustations limited to the distal segment, whereas neglected stents are more frequently associated with extensive, multi-site encrustations involving the shaft and proximal loop.